Late-onset nonketotic hyperglycinemia and spinocerebellar degeneration by Steiman, Gerald S. et al.
June 1979 
The Journa lo fPEDIATRICS  907 
Late-onset nonketotic hyperglycinemia and 
spinocerebellar degeneration 
Investigation of a 15-year-oM boy with progressive optic atrophy and spinocerebellar degeneration 
revealed elevated plasma, cerebrospinal fluid, and urine glycine concentrations. During an oral glycine 
loading test, the patient's plasma glycine concentration rose to a higher level than control values, 
although the initial rate of rise was slower; there was no concomitant rise in the plasma serine 
concentration. An oral serine loading test resulted in a prompt rise of both glycine and serine serum 
concentrations. The renal glycine clearance was elevated, and the renal tubular glycine reabsorption was 
diminished. These findings of decreased intestinal uptake and increased renal tubular glycine clearance 
suggest that a generalized derangement ofglycine entry into cells may account for the phenotypic 
manifestations of the disorder. 
Gerald S. Steiman, M.D., Marc Yudkoff, M.D., Peter H. Berman, M.D., 
Bonnie Blazer-Yost, B.A., and Stanton Segal, M.D.,* Philadelphia, Pa. 
THE HYPERGLYCINEMIA SYNDROMES, a clinically 
and biochemically heterogeneous group of metabolic 
disorders, are classified into ketotic and nonketotic ate- 
gories. The hyperglycinemia associated with ketosis is a 
secondary phenomenon, reflecting an inhibition of 
glycine oxidation by the accumulation of organic acids." 2 
Nonketotic hyperglycinemim in contrast, represents a 
primary disorder of glycine metabolism. Patients with 
either form of hyperglycinemia usually present early in 
infancy with a severe neurologic syndrome. A single 
sibship has been reported with nonketotic hyperglycine- 
mia and a syndrome of progressive spastic paraparesis 
with onset between 2 and 23 years of age? 
We describe the clinical and biochemical findings in an 
adolescent boy with nonketotic hyperglycinemia nd 
spinocerebellar degeneration with optic atrophy. An 
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unusual finding was diminished intestinal and renal 
tubular reabsorption of glycine. 
CASE REPORT 
Patient G.K. is a 15-year-old boy born in Kfarsghab, Lebanon, 
who came to the United States at the age of 2 years. He was the 
first born of dizygotic twins to nonconsanguineous parents. Birth 
history and early developmental milestones were within normal 
limits. A preschool examination atage 4 disclosed bilateral optic 
atrophy with nystagmus and mild spastic paraparesis. The 
spasticity was progressive; by the age of 9 he required lower limb 
braces to assist with ambulation. Presently, school performance is 
age appropriate although he attends classes for the visually 
handicapped. There is no bladder or bowel dysfunction. Results 
of examinations of both parents, an older brother, and a twin 
sister were within normal imits. 
On physical examination, all abnormalities were restricted to 
the nervous ystem. Mental status examination was normal, with 
a mental age score of 71. There was bilateral optic atrophy with 
visual acuity in the left eye at finger counting, and in the right eye 
at 6/60. The extraocular movements were full, with rapid 
horizontal rotatory nystagmus noted in all positions of gaze. 
There was moderate dysmetria in the upper extremities. In the 
lower extremities, there was severe spastic paraparesis with 
bilateral footdrop. Reflexes were normal in the upper extremities, 
brisk at the knees, and absent at the ankles. Below the knees there 
was a mild vibratory and proprioceptive s nsory loss. 
Laboratory investigation revealed normal routine chemistry 
values and hematologic ndices. Spinal fluid protein concentra- 
tion was 19 mg/dl with a normal electrophoretic pattern. Results 
0022-3476/79/600907 + 05500.50/09 1979 The C. V. Mosby Co. VoL 94. No. 6, pp, 907-911 
908 Steiman et al. l'he Journal of Pediatrics 
June I979 
Table I. Plasma amino acid levels (mg/dl _+ SEM) 
Patient [ Father Mother 
m 
Gtycine 4.87 ___ 0.84 1.86 1.66 
Serine 0.98 _+ 0.12 1.20 1.29 
Brother Sister 
1.32 1.52 
1.06 1.1.7 
, Control* 
1.64 + 0.12 
1.66 ___ 0.04 
*Based on 15 adult controls. 
Table II. Urinary amino acid excretion (mg/24 hours _+ SEM) 
Patient l Father l Mother 
Glycine 1,317.2 101.9 290.6 
Sefine 47.8 39.5 82.8 
Proline Tr 2.07 Tr 
HydroxyproUne 0 0 0 
Brother ] Sister 
175.0 112.5 
65.8 40.6 
0 0 
0 0 
Control* 
112.8 + 10.4 
(47.6-207.4)i" 
45.4 _ 4.0 
(21.2-82.5 
Tr 
0 
*Based on 18 adult controls. 
tFigurez in parentheses r present range. 
Table III, Renal amino acid clearance and reabsorption 
Clearance* 
(ml/min/ 
1.73 m'-') 
% Reab- 
Amino acid Control~ sorption 
Glycine 90.5 2.7-5.8 29.8 96.7 
Serine 13.5 1.9-3.0 90.2 97.0 
Threonine 4.8 0.8-1.5 96.5 99.0 
Glutamine 4.7 0.7-1.8 96.5 99.0 
Alanine 3.1 0.3-0.9 97.8 99.2 
Cystine 6.7 0.7-2.9 95.1 98.4 
Tyrosine 5.9 1.0-1.7 95.7 98.4 
Phenylal- 2.7 0.7-1.4 98.1 98.8 
amine 
Lysine 4.5 0.2-1.9 96.7 99.5 
Histidine 36.6 4.7-9.1 7.3.4 92.3 
Control~ 
*Based on the average oftwo 20-minute clearance p riods. 
tFrom data of Cusworth and Dent, 196W 
~From data of Scriver et al, 1964." 
of skull radiographs and an electroencephalogram were normal. 
A computerized axial tomographic scan demonstrated large 
intrapeduncular, mbient, and supraseUar cisterns, suggesting 
pontine and cerebellar atrophy. Results of motor and sensory 
nerve conduction studies in the upper extremities were normal. 
In the lower extremities, normal motor conduction velocities and 
sensory latencies with diminished amplitudes suggested an axo- 
nal neuropathy. Gas chromatographic analysis of blood and 
urine did not disclose any organic acid abnormalities. 
METHODS 
Venous blood for amino acid analysis was drawn into a 
test tube containing heparin as an anticoagulant. The 
plasma was immediately separated by centrifugatton and 
deproteinized with 3% sulfosalicyclic acid (1:1 v/v). Urine 
for amino acid analysis was collected on ice without the 
use of a preservative, and diluted with four volumes of 3% 
sulfosalicyclic acid prior to analysis. In most instances, the 
amino acid composition was determined on fresh samples. 
When this was not possible, the samples were kept frozen 
at -20~ until the assay could be performed. (Amino acid 
quantitation was performed on a Beckman Model 119 
amino acid analyzer.) 
Amino acid-loading tests were performed in the morn- 
ing after an overnight fast. Baseline blood samples were 
obtained, and subjects then were given a single oral dose 
of either glycine (300 mg/kg) or serine (150 mg/kg) as a 
10% solution in water. Subsequent blood samples for 
amino acid analysis were withdrawn at 30, 60, 120, 180, 
and 240 minutes. 
The amino acid clearance study was performed in the 
morning after an overnight fast. An intravenous infusion 
of isotonic saline was administered at a rate of 100 
ml/hour for two hours. In addition, water (500 ml/hour) 
was given by mouth during this two-hour preliminary 
period. Inulin was then administered as a 60 mg/kg bolus 
followed by an infusion of 10% inulin at 25 mg/hour. A 
separate saline infusion was continued at 150 ml/hour for 
the duration of the clearance study. After one hour, the 
first of two 20-minute collection periods was started after 
the patient had voided. At the midpoint of each 20-minute 
collection period, blood was withdrawn for determination 
of amino acids, creatinine, and inulin. Inulin was deter- 
mined by the method of Waugh. 4
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Fig. 1. Plasma glycine levels following oral glycine load (300 
mg/kg) in patient and five adult controls. 
RESULTS 
The fasting plasma glycine levels were consistently 
elevated in the patient but not in his parents or his siblings 
(Table I). The plasma concentrations of all other amino 
acids, including serine, were within normal limits. The 
cerebrospinal fluid glycine concentration was five times 
the value reported for normal adults. 5The CSF amino- 
gram was otherwise unremarkable. 
The patient's urinary glycine excretion was nearly seven 
times higher than were control values (Table II). Serine 
excretion was normal. Praline and hydroxyproline were 
excreted only in trace amounts, thus eliminating imino- 
glycinuria s a diagnostic possibility. 6 Urinary amino acid 
excretion was normal in other family members with the 
exception of the patient's mother and brother, in whom 
glycine excretion was slightly higher than were control 
values (Table II). 
Renal amino acid clearance data are given in Table III. 
Glomerular filtration rate, as determined by inulin clear- 
ance, was 140 ml/minute/1.73 m~ and 130 ml/minute/ 
1.73 m s during the two clearance periods. Renal clearance 
of all amino acids was somewhat elevated compared with 
published control values. ~ The clearance of serine and 
histidine was more than four times normal values. The 
most striking abnormality was the elevated glycine clear- 
ance, which was approximately 16 times the upper limit 
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Fig. 2. Plasma serine levels following oral glycine load (300 
mg/kg) in patient and five adult controls. 
for adult norms and nearly two-thirds the glomerular 
filtration rate. This exceptional elevation of glycine clear- 
ance was also reflected in a marked diminution of tubular 
fractional glycine reabsorption. 
Oral glycine-loading tests in normal adults resulted in a 
sharp rise of plasma glycine concentration with a peak 
value occurring at one to two hours (Fig. 1). Levels 
declined steadily thereafter, approaching baseline values 
by the fourth hour. This fluctuation of plasma glycine 
concentration was accompanied by a parallel alteration of 
the. plasma serine concentration, which also reached a 
peak value at one to two hours after the oral glycine load, 
and was only modestly elevated by the fourth hour. The 
results of the glycine-loading tests in the patient's family 
were essentially indistinguishable from control data with 
respect to both glycine (Fig. 1) and serine (Fig. 2) 
concentrations. In contrast, administration of an oral 
glycine load to the patient revealed a marked delay in the 
rise of blood glycine, with the peak value not occurring 
until the three-hour point. The slope of the curve describ- 
ing the subsequent decline of blood glycine was compara- 
ble to that of the control group (Fig. 1), suggesting a
defect of intestinal glycine uptake. A defect in som e aspect 
of the conversion of glycine to serine is suggested by the 
minimal rise of the serine concentration after the glycine 
load (Fig. 2). 
The administration of an oral serine load caused a 
comparable rise of the blood serine concentration i  both 
the patient and adult controls, thus suggesting the absence 
in the patient of a defect of intestinal serine uptake. The 
plasma glycine concentration, however, rose much more 
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Fig. 3. Plasma glycine levels following oral serine load (150 
mg/kg) in patient and two adult controls. 
sharply in the patient (Fig. 3). This indicates that the 
Process of glycine formation from serine in the patient is 
intact but that the subsequent disposal of the glycine so 
formed is impaired. 
D ISCUSSION 
The clinical presentation of our patient clearly differs 
from that of patients with the "typical" forms of hyper- 
glycinemia. He was well until age 4 years, when the first 
signs and symptoms of optic atrophy and spinocerebellar 
degeneration were appreciated. Convulsions and mental 
retardation were not present. The patient's clinical course 
and biochemical findings are similar to those of the three 
brothers describe d by Bank and Morrow. ~ These young- 
sters appear to have a discrete syndrome Of nonketotic 
hyperglycinemia and spinocerebellar degeneration. The 
fact that all these children are of Lebanese xtraction also 
suggests that they have a similar genotype. 
The likely cause of most cases of nonketotic hypergly- 
cinemia is a defect of the glycine cleavage system, which 
mediates the oxidation of the C-I carbon of glycine to 
carbon dioxide and the transfer of the C-2 carbon to 
another glycine molecule to form serine. 8-'~ In our patient, 
the absence of a rise of blood serine following an oral 
glycine load and the sustained elevation of the blood 
glycine are consistent with such a defect. In both our 
patient and in infants with nonketotic hyperglycinemia, 
the administration ofan oral serine load caused a prompt 
increase of blood g!ycine concentration. The obvious 
differences between the clinical presentation of our 
patient and that of infants with nonketotic hyperglyci- 
nemia indicate that the two groups do not share an 
identical metabolic defect. Since the glycine cleavage 
system is comprised of a network of distinct proteins?' 
ample opportunity would exist for a broad heterogeneity 
of phenotypic expression, depending upon the nature of 
specific mutations. 
The data obtained with the glycine loading test and 
renal amino acid clearance study are consistent also with a 
defect of glycine transport as the cause of the patient's 
deranged glycine metabolism. Although plasma glycine 
values after an oral glycine load were much higher than 
control values, the initial rate of rise of plasma glycine was 
much lower than control values. Defective intestinal 
glycine transport could explain the diminished uptake, 
whereas impaired glycine transport into other tissues 
could explain the sustained hyperglycinemia. The absence 
of a rise of the blood serine concentration following the 
g!ycine load would then reflect the failure of glycine 
uptake into cells mediating the glycine-serine interconver- 
sion. The markedly increased renal glycine clearance 
suggests a defect of renal tubular glycine reabsorption. 
This defect is not referable to hyperglycinemia alone, 
since glycine clearance and reabsorption have been 
normal in other patients with nonketotic hyperglycine- 
mia. ~2 Furthermore, studies in the dog indicate that a 
blood glycine concentration many times higher than the 6 
to 7 mg/dl measured in our patient would have to exist 
before significant overflow glycinuria would be 
expected. '3 Of interest is the fact tha t the patient's glycine 
clearance is greater than that observed in familial imino- 
glycinuria.0.14 The coexistence of a glycine transport 
defect in both intestines and kidney has not been hitherto 
described. 
The important rote played by glycine as an inhibitory 
neurotransmitter in the spinal cord, medulla, and cerebel- 
lum ..... suggests a physiologic basis for the relationship 
between the hyperglycinemia and the patient's clinical 
presentation. The devastating symptoms of nonketotic 
hyperglycinemia, which commonly results in death during 
the first month of life, may be referable to profound 
impairment of neurotransmission by increased glycine 
levels in the brain and spinal cord. Patients with both 
ketotic and nonketotic hyperglycinemia lso have 
dysmyelination i  those areas of the brain which become 
myelinated after birth. 17 Similar lesions have been 
observed in many other amino-acidopathies, including 
maple syrup urine disease ..... and phenylketonuria." A 
likely cause of this abnormality is an inhibition of 
myelin-protein synthesis by intracytoplasmic amino acid 
imbalance. '7 It is not clear in our patient why such 
demyelination, if indeed present, should be restricted to 
the cerebellum and spinal cord, although it may be 
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significant hat these are the brain regions of highest 
glycine concentration i patients with nonketotic hyper- 
glycinemia. 
The genetics of this hyperglycinemic variant probably 
conform to an autosomal-recessive pattern. Oral glycine 
loading tests were performed in the patient's parents and 
siblings. The results did not differ from control values. All 
other family members are clinically well. The only abnor- 
mality detected in the family was increased 24-hour urine 
glycine excretion in the patient's mother. This finding, 
together with the fact that the patients reported by Bank 
and Morrow ~ were all males, raises the possibility of an 
X-linked pattern of inheritance. The absence of any 
spinocerebellar degeneration in male ancestors of our 
patient's mother, however, is evidence against a mutation 
on the X chromosome. 
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